Establishment Labs Holdings Inc. (NASDAQ: ESTA) is a Healthcare company (Medical - Devices) with a market capitalization of $2.1B. The Maz Rating grades it against the other companies in its sector.
Establishment Labs Holdings Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $69.51, Establishment Labs Holdings Inc. trades at 7.8x sales and 135.6x book value. Over the last twelve months it generated about $264M of revenue and a net loss of $38M. It runs a gross margin of 70.2%, an operating margin of -6.6% and a net margin of -14.6%. It shows return on equity of -203.6%, return on invested capital of -5.0% and a free cash flow yield of -1.1%. On the balance sheet: a debt-to-equity ratio of 17.28 and a current ratio of 3.57. Over the past 52 weeks the share price ranged from $53.16 to $97.59, with a beta of 1.00.
Establishment Labs Holdings Inc. does not currently pay a dividend.
14 Wall Street analyst ratings cover the stock: 13 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Establishment Labs Holdings Inc. (ESTA) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 13.1% / 30% · (Cash+Inv) / Mkt Cap (36m) 3.72% / 30% · Interest income / Revenue 0.06% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 13.1% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 3.72% / 33% · Receivables / Mkt Cap (36m) 3.82% / 49% · Interest income / Revenue 0.06% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 13.1% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 3.72% / 33.33% · Receivables / Mkt Cap (24m) 3.82% / 33.33% · Interest income / Revenue 0.06% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 73.9% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 20.5% / 33.33% · Receivables / Avg Assets (4Q) 21.7% / 33.33% · Interest income / Revenue 0.06% / 5% | Fail |
| FTSE | Debt / Total Assets 74.6% / 33.33% · (Cash+ST Inv) / Total Assets 21.1% / 33.33% · (Cash+Recv) / Total Assets 42.8% / 33.33% · Interest income / Revenue 0.06% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Establishment Labs Holdings Inc. (ESTA) passes 3 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global and Dow Jones, and fails MSCI and FTSE.
Yes. Establishment Labs Holdings Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
About 0.06% of each dividend: Establishment Labs Holdings Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.